Need to Face Liver Cirrhosis after HCV Cure with Antivirals

Autor: Pablo Barreiro, Ana Arias, Laura Benitez, Vicente Soriano, Carmen de Mendoza

Publikováno v: EBioMedicine, Vol 24, Iss C, Pp 24-25 (2017)
EBioMedicine
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid

Background There is currently no anti-fibrotic drug therapy available to treat hepatitis C virus (HCV) cirrhosis. The aim of this study was to assess the safety, tolerability, and anti-fibrotic effect of PRI-724, a small-molecule modulator of Wnt sig

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19560635ad7662d3551076ef6e0bdd43
http://www.sciencedirect.com/science/article/pii/S2352396417303390